Neuronetics (STIM) Shareholder's Equity Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.44% |
| Dec 31, 2025 | -17.48% |
| Sep 30, 2025 | 191.61% |
| Jun 30, 2025 | 62.52% |
| Mar 31, 2025 | 42.94% |
| Dec 31, 2024 | -6.99% |
| Sep 30, 2024 | -75.27% |
| Jun 30, 2024 | -57.37% |
| Mar 31, 2024 | -42.80% |
| Dec 31, 2023 | -40.08% |
| Sep 30, 2023 | -39.77% |
| Jun 30, 2023 | -33.53% |
| Mar 31, 2023 | -36.88% |
| Dec 31, 2022 | -33.01% |
| Sep 30, 2022 | -30.84% |
| Jun 30, 2022 | -29.58% |
| Mar 31, 2022 | -24.88% |
| Dec 31, 2021 | 234.11% |
| Sep 30, 2021 | 231.45% |
| Jun 30, 2021 | 230.05% |
| Mar 31, 2021 | 179.29% |
| Dec 31, 2020 | -46.73% |
| Sep 30, 2020 | -49.42% |
| Jun 30, 2020 | -50.78% |
| Mar 31, 2020 | -44.19% |
| Dec 31, 2019 | -32.64% |
| Sep 30, 2019 | -28.84% |
| Jun 30, 2019 | 129.14% |
| Mar 31, 2019 | 133.05% |
| Dec 31, 2018 | 136.88% |
| Dec 31, 2017 | -8.77% |